Antibiotic Accelerator From BARDA Nears Investment Stage
This article was originally published in The Pink Sheet Daily
Executive Summary
Federal funding could pay to help early antibiotic discovery efforts with 'fragile' pipeline still struggling.
You may also be interested in...
FDA Worries About Off-Label Use, Stewardship With Limited-Population Approval Pathway
FDA asks groups how it can help ensure prescribing is limited for products approved under proposed new pathway, but several say, other than labeling, it may be out of the agency’s hands.
US FDA Likely To Embrace In-Person, Remote Combo For Facility Inspections Going Forward
The system likely will evolve as the post-pandemic world unfolds, but adds to the list of agency programs expecting to continue using virtual platforms once in-person activities are no longer restricted by COVID-19.
US FDA/Industry Thinking PDUFA VIII Could Be A Hybrid Negotiation
Virtual meetings proved successful, and could be allowed again when the next round of user fee reauthorization talks convene.